Innovative contrast agents for more… – Information Centre – Research & Innovation
© Rambutano – fotolia.com
Current on seventeen July 2020
The EU-funded CONQUER venture focused on improving and increasing the flexibility of contrast agents. These are substances that can be administered prior to magnetic resonance imaging (MRI) scans to much more obviously and exactly distinguish different tissues and fluids in the human body: from muscle mass, cartilage and nerves to most cancers tumours and the movement of blood by means of arteries, veins and the mind.
The engineering is indispensable for comprehending and diagnosing condition as very well as developing new treatments. However, the use of contrast mechanisms in MRI scans has been constrained simply because of time and expense things, as very well as concerns about exposure to some agents this kind of as people centered on the unusual-earth element gadolinium.
The CONQUER staff for that reason sought superior and smarter possibilities, which include contrast agents that can be turned on or off remotely by altering magnetic fields in purchase to make scans of different tissues much more precise and versatile.
We have delivered a evidence of theory for a new contrast system that offers two positive aspects. We now have the likely to change the contrast on and off, and we use an choice agent to gadolinium about which there is open debate all-around likely toxicity challenges, suggests venture coordinator Hermann Scharfetter at Graz College of Technologies in Austria.
The CONQUER teams analysis focused on a versatile contrast strategy known as quadrupole leisure enhancement which operates on the basis of how indicators generated by the spins of protons inside tissues decay, or relax, about time as they interact with the contrast agent. As a substitute of gadolinium-centered substances, the CONQUER staff applied novel bismuth-centered agents.
We have proven for the initially time that quadrupole leisure improvement of solvent protons by the spin of bismuth nuclei is possible in liquids. This opens up novel avenues for even more analysis in this location, Scharfetter suggests.
To help the use of new contrast agents, the venture companions also produced new instruments for MRI scanners, which include novel elements that have been equipped experimentally to a scientific 3T MRI scanner, and which have resulted in a patent application.
Scharfetter and his staff are continuing analysis in the location with new assignments in the pipeline, driving ahead promising places of analyze focused in distinct on optimising nanoparticles in novel contrast agents. This ongoing perform could drastically enrich the means of MRI engineering to produce a further comprehending of condition and even much more effective and correct diagnoses for sufferers.
